Researchers from Genetech have developed a new way to deliver drugs across the blood-brain barrier. The new technique — not to be confused with another recent method — uses a double-sided antibody that targets enzymes of a harmful degenerative protein in monkeys. Delivering molecules in this way could assist in the treatment of brain disorders such as Alzheimer's.